The PI3K/AKT/MTOR signaling pathway also plays a key role in cancer biology, first generation MTOR inhibitors were approved for treatment of multiple cancer types, including renal, breast and some brain cancers [44]. The gene discussed is MTOR; the disease is brain cancer.